Epsilon M&A Deal Report - AQTIS Medical
Transaction Multiples for the Valuation of Private Companies
Sinclair IS Pharma / AQTIS Medical
No EMAT :
63385
Announced Date :
25/03/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Sinclair IS Pharma
Target :
AQTIS Medical
Country :
Netherlands
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
AQTIS Medical™ specialises in the research, development, manufacturing and commercialization of innovative medical devices, specifically designed for minimal invasive therapies within medical...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 14/01/2014 | Alliance Pharma | Irenat | Germany | * | 63373 |
| 13/03/2014 | Vectura Group | Activaero | Germany | ** | 63201 |
Source: Epsilon Research / EMAT
